Cancer Drug News Protected: Tecartus® (Brexucabtagene Autoleucel) CAR T-cell therapy now funded in Australia for the treatment of relapsed or refractory mantle cell lymphoma (r/r MCL)
Fast-tracked cancer drug candidate causes substantial levels of mutations and must be investigated for risk of secondary cancer
Breast Cancer Sea sponge drug could boost advanced breast cancer survival by five extra months November 3, 2014 The cancer drug eribulin, originally developed from sea sponges, could give women with advanced triple…
Cancer Drug News Exceptional Responders November 3, 2014 By Richard Saltus – Dana-Farber Cancer Institute. Finding genetic causes of dramatic cancer drug responses could…
Cancer Drug News Aspirin may cut mortality in nonmetastatic prostate cancer October 27, 2014 Daily aspirin use, even at low doses, may reduce mortality among men with high-risk non…
Cancer Drug News Cancer drug discovery system is broken, global summit hears October 27, 2014 The global system for discovering new cancer drugs is ‘broken’, and failing to turn dramatic…
Cancer Drug News Breast cancer drug holds promise in combination therapy for Ewing sarcoma October 27, 2014 Ewing sarcoma tumours disappeared and did not return in more than 70 percent of mice…
Cancer Drug News No Advertising Please: prescribers need evidence, not marketing October 20, 2014 By Martin Tattersall, Professor of Cancer Medicine, University of Sydney. The recent launch of the No…
Cancer Drug News Australian doctors to ban drug company reps from visiting surgeries October 14, 2014 By Melissa Davey – The Guardian. GPs say the No Advertising Please campaign will help…
Cancer Drug News Mutations caused patient’s dramatic response to everolimus October 14, 2014 The DNA of a woman whose lethal thyroid cancer unexpectedly “melted away” for 18 months has revealed…
Cancer Drug News Novartis works with Bristol-Myers Squibb to test lung cancer drugs October 7, 2014 Swiss pharma group Novartis AG said on Monday it would work with Bristol-Myers Squibb Co…
Cancer Drug News Nine-valent HPV vaccine may prevent nearly 90 percent of cervical cancers October 7, 2014 Because nine human papillomavirus (HPV) subtypes were found to cause the majority of cervical precancers,…